Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS.

MLA

Nassif, Michael E., et al. “Changes in Disease-Specific versus Generic Health Status Measures after Left Ventricular Assist Device Implantation: Insights from INTERMACS.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, vol. 36, no. 11, Nov. 2017, pp. 1243–49. EBSCOhost, https://doi.org/10.1016/j.healun.2017.05.023.

APA

Nassif, M. E., Spertus, J. A., Jones, P. G., Fendler, T. J., Allen, L. A., Grady, K. L., & Arnold, S. V. (2017). Changes in disease-specific versus generic health status measures after left ventricular assist device implantation: Insights from INTERMACS. The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 36(11), 1243–1249. https://doi.org/10.1016/j.healun.2017.05.023

Chicago

Nassif, Michael E, John A Spertus, Philip G Jones, Timothy J Fendler, Larry A Allen, Kathleen L Grady, and Suzanne V Arnold. 2017. “Changes in Disease-Specific versus Generic Health Status Measures after Left Ventricular Assist Device Implantation: Insights from INTERMACS.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 36 (11): 1243–49. doi:10.1016/j.healun.2017.05.023.